Financials
- Market Capitalization 3.49 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-43.37
市销率
7.34
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1577 | DNLI Denali Therapeutics Inc. - Common Stock | 22.53 USD | -0.53% | -15.21% | +1.85% | +39.33% | 3.58 B USD | ||
| 1582 | RCUS Arcus Biosciences, Inc. Common Stock | 27.76 USD | -2.05% | -5.71% | +13.63% | +201.74% | 3.49 B USD | ||
| 1616 | DYN Dyne Therapeutics, Inc. - Common Stock | 23.81 USD | +0.13% | +3.66% | +27.12% | +1.71% | 3.40 B USD | ||
| 1627 | ALMS Alumis Inc. - Common Stock | 26.50 USD | -2.86% | -14.43% | +14.82% | +487.58% | 3.27 B USD |